medicinal plants and natural active compounds for cancer … · 2019. 7. 30. · 2...

3
Editorial Medicinal Plants and Natural Active Compounds for Cancer Chemoprevention/Chemotherapy Hilal Zaid, 1,2 Michael Silbermann, 3 Alaa Amash, 4 Dan Gincel, 5 Essam Abdel-Sattar, 6 and Nazli B. Sarikahya 7 1 Qasemi Research Center, Al-Qasemi Academic College, P.O. Box 124, 30100 Baqa Al-Gharbiyye, Israel 2 Faculty of Arts and Sciences, Arab American University of Jenin, P.O. Box 240, Jenin, State of Palestine 3 Technion-Israel Institute of Technology, Middle East Cancer Consortium, Haifa, Israel 4 e Research Institute of the McGill University Health Centre, Montreal, QC, Canada 5 Maryland Technology Development Corporation (TEDCO), Columbia, MD, USA 6 Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo, Egypt 7 Department of Chemistry, Faculty of Science, Ege University, Bornova, 35100 Izmir, Turkey Correspondence should be addressed to Hilal Zaid; [email protected] Received 16 March 2017; Accepted 20 March 2017; Published 9 April 2017 Copyright © 2017 Hilal Zaid et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cancer is a cohort of diseases in which abnormal cells divide without control and are able to invade other tissues (through the blood and lymph systems). Cancer has devastating consequences for the patients’ life and indeed is a leading cause of death worldwide. More than 100 different types of cancer are known and are usually named by the organ or type of cell where they start; for example, a cancer that begins in the colon is called colon cancer. e growing incidence of these diseases due to the rising age of the population poses a considerable burden on the public health system. Statistical studies indicate that cancer strikes more than one-third of the population and it is the cause of more than 20% of all deaths. Cancer is caused usually due to abnormalities in the DNA of the affected cells leading to an extra mass of tissue called a tumor. Tumors may be benign (not cancer) or malignant (cancer) [1, 2]. e incidence of cancer might increase in many tissues because of chronic inflammation (e.g., all gastrointestinal). Cancer may develop in cells that are selected for resistance to inflammatory products by virtue of overexpressing anti- apoptotic proteins [3]. Current treatments for cancer, besides surgery, are heavily based on cytotoxic regimens of com- pounds and radiation that interfere with the cellular replica- tion system and thus aim to primarily target rapidly dividing cells. However, due to low selectivity, these treatments show many side effects and are, more importantly, becoming ineffective due to the development of resistance. A promising and new approach to fight cancer is to develop agents that abrogate the cancer’s capability to become resistant. Herbal derived drugs (e.g., polyphenols, brassinosteroids, and taxol) are desired for anticancer treatment, as they are natural and readily available. Currently, a few plant products are being used to treat cancer. However, the molecular mechanism of the anticancer effect of some of those plants products and dissecting new products from those plants await further studies [2]. is special issue provides a comprehensive overview on anticancer traditional herbal medicine. e greater majority of contributions arrived from the Far East (China, Korea, Japan, and Taiwan) and the rest from Africa (Uganda, Algeria) and the Middle East (Palestine). We were highly impressed by both the design of the experiments and their high-class execution. e technologies used are up-to-date and convincing. Most of the studies in this issue applied in vitro (using established cell line) and in vivo (animal models and human patients) tests to evaluate the efficacy of anticancer medicinal plants and phytochemicals activity and their action of mechanism. e current special issue involves a relatively large variety of cancers such as leiomy- oma, melanoma, hepatoma, breast, prostate, gastric, thyroid, Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2017, Article ID 7952417, 2 pages https://doi.org/10.1155/2017/7952417

Upload: others

Post on 20-Feb-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

  • EditorialMedicinal Plants and Natural Active Compounds forCancer Chemoprevention/Chemotherapy

    Hilal Zaid,1,2 Michael Silbermann,3 Alaa Amash,4 Dan Gincel,5

    Essam Abdel-Sattar,6 and Nazli B. Sarikahya7

    1Qasemi Research Center, Al-Qasemi Academic College, P.O. Box 124, 30100 Baqa Al-Gharbiyye, Israel2Faculty of Arts and Sciences, Arab American University of Jenin, P.O. Box 240, Jenin, State of Palestine3Technion-Israel Institute of Technology, Middle East Cancer Consortium, Haifa, Israel4The Research Institute of the McGill University Health Centre, Montreal, QC, Canada5Maryland Technology Development Corporation (TEDCO), Columbia, MD, USA6Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo, Egypt7Department of Chemistry, Faculty of Science, Ege University, Bornova, 35100 Izmir, Turkey

    Correspondence should be addressed to Hilal Zaid; [email protected]

    Received 16 March 2017; Accepted 20 March 2017; Published 9 April 2017

    Copyright © 2017 Hilal Zaid et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Cancer is a cohort of diseases in which abnormal cells dividewithout control and are able to invade other tissues (throughthe blood and lymph systems). Cancer has devastatingconsequences for the patients’ life and indeed is a leadingcause of death worldwide. More than 100 different types ofcancer are known and are usually named by the organ or typeof cell where they start; for example, a cancer that begins inthe colon is called colon cancer. The growing incidence ofthese diseases due to the rising age of the population posesa considerable burden on the public health system. Statisticalstudies indicate that cancer strikesmore than one-third of thepopulation and it is the cause of more than 20% of all deaths.Cancer is caused usually due to abnormalities in the DNAof the affected cells leading to an extra mass of tissue calleda tumor. Tumors may be benign (not cancer) or malignant(cancer) [1, 2].

    The incidence of cancer might increase in many tissuesbecause of chronic inflammation (e.g., all gastrointestinal).Cancer may develop in cells that are selected for resistanceto inflammatory products by virtue of overexpressing anti-apoptotic proteins [3]. Current treatments for cancer, besidessurgery, are heavily based on cytotoxic regimens of com-pounds and radiation that interfere with the cellular replica-tion system and thus aim to primarily target rapidly dividingcells. However, due to low selectivity, these treatments show

    many side effects and are, more importantly, becomingineffective due to the development of resistance. A promisingand new approach to fight cancer is to develop agents thatabrogate the cancer’s capability to become resistant. Herbalderived drugs (e.g., polyphenols, brassinosteroids, and taxol)are desired for anticancer treatment, as they are natural andreadily available. Currently, a few plant products are beingused to treat cancer. However, the molecular mechanismof the anticancer effect of some of those plants productsand dissecting new products from those plants await furtherstudies [2].

    This special issue provides a comprehensive overview onanticancer traditional herbal medicine. The greater majorityof contributions arrived from the Far East (China, Korea,Japan, and Taiwan) and the rest from Africa (Uganda,Algeria) and the Middle East (Palestine). We were highlyimpressed by both the design of the experiments and theirhigh-class execution. The technologies used are up-to-dateand convincing. Most of the studies in this issue appliedin vitro (using established cell line) and in vivo (animalmodels and human patients) tests to evaluate the efficacyof anticancer medicinal plants and phytochemicals activityand their action of mechanism. The current special issueinvolves a relatively large variety of cancers such as leiomy-oma, melanoma, hepatoma, breast, prostate, gastric, thyroid,

    HindawiEvidence-Based Complementary and Alternative MedicineVolume 2017, Article ID 7952417, 2 pageshttps://doi.org/10.1155/2017/7952417

    https://doi.org/10.1155/2017/7952417

  • 2 Evidence-Based Complementary and Alternative Medicine

    colorectal, osteosarcoma, and squamous cell cancer, whileaddressing features such as apoptosis and growth factors asthe indicative factors.

    By and large, this new special issue contributes a signif-icant and substantial collection of well documented data toour armamentarium in fighting cancer. An additional issueto be emphasized is the fact that the herbal remedies arenot confined to the effort to cure cancer but also to alleviatecancer patients undergoing treatment: chemotherapy. We areconvinced that, by increasing the quality of life especiallyduring the last stage of the cancer journey, we are doing anenormous service to the suffering patient and his caring rela-tives. As physicians, we should never forget that, concomitantwith trying to cure the tumor, our obligation is to care for thepatient as a human being keeping his self-dignity until hislast day and hours. The nonconventional approach of usingnatural herbal substances provides us with an important toolto minimize pain, suffering, and hopelessness. It is for thatreason that we encourage more scientists and clinicians toproceed with their scientific work of characterizing morenatural compounds and try to adjust them for clinical use.

    Complementary medicine has suffered for many yearsfrom lack of solid evidence in order to justify its use inclinical medicine. It appears that we have reached the phasethat this claim is less and less valid, as more evidence-basedproducts are allowed to be commercialized and used underthe supervision of an authoritative professional (oncologist,palliative care specialist, pain specialist, and others).

    For this special issue, the editorial office received forty-six papers and after rigorous peer review process seven-teen papers were accepted for publication. The publishedarticles deal with the physiological as well as molecularand biochemical efficacy of medicinal plants and naturalactive compounds in cancer and tumorigenesis treatmentand prevention in vitro and in vivo. Out of the seventeenacceptedmanuscripts, two articles are very informative high-class review articles. Seven papers used in vivo rat model fortheir studies; four out of themused clinical trials. In nine pub-lications, the authors used in vitro model utilizing colorec-tal, hepatoma, squamous carcinoma, leiomyoma, prostate,osteosarcoma, gastric, thyroid, melanoma, and breast cancercell lines and primary cell culture.

    Acknowledgments

    We are thankful to all contributors of this special issue fortheir valuable research papers. We are grateful to the review-ers for their constructive criticisms and timely response thatmade this special issue possible. Our sincere thanks andgratitude go to the editorial board of eCAM for inviting us toedit this special issue. The editorial board hope that readerswill enjoy this special issue.

    Hilal ZaidMichael Silbermann

    Alaa AmashDan Gincel

    Essam Abdel-SattarNazli B. Sarikahya

    References

    [1] J. Wang, D. L. Yang, Z. Z. Chen, and B. Gou, “Associations ofbody mass index with cancer incidence among populations,genders, and menopausal status: a systematic review and meta-analysis,” Cancer Epidemiology, vol. 42, pp. 1–8, 2016.

    [2] H. Zaid, M. Silbermann, E. Ben-Arye, and B. Saad, “Greco-Arab and Islamic herbal-derived anticancer modalities: fromtradition to molecular mechanisms,” Evidence-Based Comple-mentary and Alternative Medicine, vol. 2012, Article ID 349040,13 pages, 2012.

    [3] J. Daragmeh,W. Barriah, B. Saad, and Zaid, “Targeting the PI3Kpathway in tumorigenesis: an in situ comprehensive study,”Oncology Letters, vol. 11, pp. 2913–2918, 2016.

  • Submit your manuscripts athttps://www.hindawi.com

    Stem CellsInternational

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    MEDIATORSINFLAMMATION

    of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Behavioural Neurology

    EndocrinologyInternational Journal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Disease Markers

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    BioMed Research International

    OncologyJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Oxidative Medicine and Cellular Longevity

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    PPAR Research

    The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

    Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Journal of

    ObesityJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Computational and Mathematical Methods in Medicine

    OphthalmologyJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Diabetes ResearchJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Research and TreatmentAIDS

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Gastroenterology Research and Practice

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Parkinson’s Disease

    Evidence-Based Complementary and Alternative Medicine

    Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com